Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 28
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Choi, Yura Jeong, Ha Jin Liu, Quan Feng Oh, Seung Tack Koo, Byung-Soo Kim, Yeni Chung, In-Won Kim, Yong Sik and Jeon, Songhee 2016. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology,

    Berman, Karen Brodaty, Henry Withall, Adrienne and Seeher, Katrin 2012. Pharmacologic Treatment of Apathy in Dementia. The American Journal of Geriatric Psychiatry, Vol. 20, Issue. 2, p. 104.

    Suzuki, Takefumi Remington, Gary Uchida, Hiroyuki Rajji, Tarek K. Graff-Guerrero, Ariel and Mamo, David C. 2011. Management of Schizophrenia in Late Life with Antipsychotic Medications. Drugs & Aging, Vol. 28, Issue. 12, p. 961.

    O'Connor, Daniel W. Sierakowski, Christine Chin, Loi Fei and Singh, Dhiren 2010. The safety and tolerability of clozapine in aged patients: A retrospective clinical file review. The World Journal of Biological Psychiatry, Vol. 11, Issue. 6, p. 788.

    Paleacu, D. Barak, Y. Mirecky, I. and Mazeh, D. 2008. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. International Journal of Geriatric Psychiatry, Vol. 23, Issue. 4, p. 393.

    Kozman, Mervat N. Wattis, John and Curran, Stephen 2006. Pharmacological management of behavioural and psychological disturbance in dementia. Human Psychopharmacology: Clinical and Experimental, Vol. 21, Issue. 1, p. 1.

    Fehr, B. S. Ozcan, M. E. and Suppes, T. 2005. Low doses of clozapine may stabilize treatment?resistant bipolar patients. European Archives of Psychiatry and Clinical Neuroscience, Vol. 255, Issue. 1, p. 10.

    Van Citters, Aricca D. Pratt, Sarah I. Bartels, Stephen J. and Jeste, Dilip V. 2005. Evidence-Based Review of Pharmacologic and Nonpharmacologic Treatments for Older Adults with Schizophrenia. Psychiatric Clinics of North America, Vol. 28, Issue. 4, p. 913.

    Jeste, Dilip V. and Dolder, Christian R. 2004. Treatment of non-schizophrenic disorders: focus on atypical antipsychotics. Journal of Psychiatric Research, Vol. 38, Issue. 1, p. 73.

    Finkel, Sanford I 2003. Behavioral and psychologic symptoms of dementia. Clinics in Geriatric Medicine, Vol. 19, Issue. 4, p. 799.

    Paleacu, Diana Mazeh, Doron Mirecki, Ilona Even, Michael and Barak, Yoram 2002. Donepezil for the Treatment of Behavioral Symptoms in Patients With Alzheimer's Disease. Clinical Neuropharmacology, Vol. 25, Issue. 6, p. 313.

    Hemels, Michiel E. Lanctot, Krista L. Iskedjian, Michael and Einarson, Thomas R. 2001. Clinical and Economic Factors in the Treatment of Behavioural and Psychological Symptoms of Dementia. Drugs & Aging, Vol. 18, Issue. 7, p. 527.

    Herrmann, Nathan 2001. Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia. The Canadian Journal of Neurological Sciences, Vol. 28, Issue. S1, p. S96.

    Madhusoodanan, Subramoniam 2001. Introduction: Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia in Geropsychiatric Patients. The American Journal of Geriatric Psychiatry, Vol. 9, Issue. 3, p. 283.

    Rojas-Fernandez, Carlos H. Lanctôt, Krista L. Allen, David D. and MacKnight, Chris 2001. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: Time for a Different Paradigm?. Pharmacotherapy, Vol. 21, Issue. 1, p. 74.

    Defilippi, Jennifer L. and Crismon, M. Lynn 2000. Antipsychotic Agents in Patients with Dementia. Pharmacotherapy, Vol. 20, Issue. 1, p. 23.

    Raicu, Roxana G. and Workman, Richard H. 2000. Management of Psychotic and Depressive Features in Patients with Vascular Dementia. Topics in Stroke Rehabilitation, Vol. 7, Issue. 3, p. 11.

    Barak, Y Wittenberg, N Naor, S Kutzuk, D and Weizman, A 1999. Clozapine in elderly psychiatric patients: Tolerability, safety, and efficacy. Comprehensive Psychiatry, Vol. 40, Issue. 4, p. 320.

    Chan, Yiu-Chung Pariser, Stephen F. and Neufeld, Gayle 1999. Atypical Antipsychotics in Older Adults. Pharmacotherapy, Vol. 19, Issue. 7, p. 811.

    Eastham, John H. and Jeste, Dilip V. 1997. Treatment of schizophrenia and delusional disorder in the elderly. European Archives of Psychiatry and Clinical Neuroscience, Vol. 247, Issue. 4, p. 209.


Safety and Effectiveness of Low-Dose Clozapine in Psychogeriatric Patients: A Preliminary Study

  • A. F. Oberholzer (a1), C. Hendriksen (a1), A. U. Monsch (a1), B. Heierli (a1) and H. B. Stähelin (a1)
  • DOI:
  • Published online: 01 September 1992

The short- and long-term treatment tolerance of low-dose clozapine was retrospectively investigated in 18 psychogeriatric patients. Discontinued use of the drug because of side effects or inefficiency was required for only four patients. In the long-term treatment group leukopenia was not observed, and disturbances of liver function appeared to be very infrequent. A second group of seven severely demented psychogeriatric inpatients who were currently being treated with low-dose clozapine underwent a withdrawal study in order to evaluate the therapeutic efficacy of the drug, measured by the NOSIE and the SCAG scales. The results indicate that for patients such as these, with paranoid or socially disturbing behavior who also tend to develop severe neurological side effects with classical neuroleptics, a low-dose administration of clozapine is an acceptable alternative treatment.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *